The Valley Desk

NCT02760602 · Interventional trial

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Overall registry status Terminated

Phase 3

Conditions Alzheimer's Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov